Q fever pneumonia

被引:30
作者
Marrie, TJ [1 ]
机构
[1] Univ Alberta, Dept Med, Edmonton, AB T6G 2M7, Canada
关键词
pneumonia; Coxiella burnetii; treatment; chronic fatigue;
D O I
10.1097/00001432-200404000-00012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review In this era of emerging infectious diseases and bioterrorism it is important to be up to date with the diagnosis and management of Q fever pneumonia. Recent findings A considerable amount of new information has emerged regarding the pathogenesis of Coxiella burnetii infection. The complete genome of this microorganism has now been sequenced and there are several unique features. The spectrum of manifestations of infection due to C. burnetii continues to expand. Some of the more recently described findings are acalculous cholecystitis, rhabdomyolysis, long-term persistence of Coxiefla, post Q fever fatigue syndrome, and hemolytic uremic syndrome. Pneumonia as a manifestation of acute Q fever shows tremendous geographic variation, being common in one area of a country such as Spain but not in another area. Summary Pneumonia continues to be an important manifestation of infection with C. burnetii. It responds to treatment with doxycycline, quinolones or macrolides.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 59 条
  • [31] Coxiella burnetii pneumonia
    Marrie, TJ
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (04) : 713 - 719
  • [32] Marrie TJ, 1999, ANTIMICROBIAL, P542
  • [33] Coxiella burnetii (Q fever) pneumonia
    Marrie, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 : S253 - S264
  • [34] Q fever
    Maurin, M
    Raoult, D
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) : 518 - +
  • [35] Q Fever in Humans and Animals in the United States
    Mcquiston, Jennifer H.
    Childs, James E.
    [J]. VECTOR-BORNE AND ZOONOTIC DISEASES, 2002, 2 (03) : 179 - +
  • [36] Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in-vitro-selected quinolone-resistant strain of Coxiella burnetii
    Musso, D
    Drancourt, M
    Osscini, S
    Raoult, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 870 - 873
  • [37] Q fever pneumonia complicated by acute respiratory distress syndrome
    Oddo, M
    Jolidon, RM
    Péter, O
    Poli, S
    Cometta, A
    [J]. INTENSIVE CARE MEDICINE, 2001, 27 (03) : 615 - 615
  • [38] ERYTHROMYCIN AND THE TREATMENT OF COXIELLA-BURNETII PNEUMONIA
    PEREZDELMOLINO, A
    AGUADO, JM
    RIANCHO, JA
    SAMPEDRO, I
    MATORRAS, P
    GONZALEZMACIAS, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (03) : 455 - 459
  • [39] Q fever 1985-1998 - Clinical and epidemiologic features of 1,383 infections
    Raoult, D
    Tissot-Dupont, H
    Foucault, C
    Gouvernet, J
    Fournier, PE
    Bernit, E
    Stein, A
    Nesri, M
    Harle, JR
    Weiller, PJ
    [J]. MEDICINE, 2000, 79 (02) : 109 - 123
  • [40] Comparative DNA microarray analysis of host cell transcriptional responses to infection by Coxiella burnetii or Chlamydia trachomatis
    Ren, Q
    Robertson, SJ
    Howe, D
    Barrows, LF
    Heinzen, RA
    [J]. RICKETTSIOLOGY: PRESENT AND FUTURE DIRECTIONS, 2003, 990 : 701 - 713